Brain-derived neurotrophic factor (BDNF) changes in rodent models of schizophrenia induced by ketamine: a systematic review.
Naunyn-Schmiedeberg's Archives of Pharmacology February 20, 2025 Atefeh Motamedi-Manesh, Mahdieh Farzin Asanjan, Hamed Fallah et al. 6 citations
Schizophrenia is a severe neuropsychiatric disorder ranking among the top ten global disability causes. In rodents, sub-chronic or chronic ketamine treatment is used for the induction of schizophrenia. Ketamine affects the function of brain-derived neurotrophic factor (BDNF), the most important neurotrophin involved in the pathophysiology of different neuropsychiatric disorders. The present...
DOI: 10.1007/s00210-025-03912-7 (opens in new tab)
Full text (opens in new tab)
Ketamine
Mice
Rats
Systematic review
+4